Pomegranate as an Antibacterial Agent against Pathogens and at the same Time Advantageous to Beneficial Bacteria: A Review
Pomegranate contains several categories of bioactive constituents such as anthocyanins, flavonols, flavanols, isoflavones, flavones, hydrolysable and non-hydrolysable tannins that possess strong antioxidant, antibacterial and anti-inflammatory properties. Researches showed that pomegranate’s juice, extracts and isolated compounds are effective against various pathogens, as Clostridium, Escherichia coli, Aggregatibacter, Acinetobacter, Bacillus, Helicobacter, Porphyromonas, Acinetobacter, Cryptococcus, Citrobacter, Alcaligenes, Prevotella, Bacteroids, Cronobacter, Achromobacter, Prevotella, Proteus, Enterococcus, Yersinia, Treponema, Serratia, Klebsiella, Mycobacterium, Lysteria, Pseudomonas, Shigella, Streptococcus, Staphylococcus, Salmonella and Vibrio giving results in many cases comparable or even better than the commercial antibiotics. Pathogens are causing several infections with different scale of severity. Pomegranate’s phytochemicals possess more than one bioactivities and thus it can treat such health issues by more than one ways, affecting more than one parameters associated to them. For example, in cases of bacteria that are causing inflammation, pomegranate is not only killing the bacteria but also by its anti-inflammatory and antioxidant activity is treating the infections caused by them, achieving faster health rather than just removing the infection’s reason (the bacteria). Even pomegranate is bactericidal towards pathogens, it is protecting and enhancing the growth of gut microbiota that is important for health maintenance. Safety tests showed that pomegranate is safe in contrast with antibiotics that are having side effects and are disturbing gut microbiota causing dysbiosis and other disorders indicating that in cases that the antibacterial activity of pomegranate is comparable to antibiotics’ activity, it could be considered as a promising alternative antibacterial agent.
How to cite this article:
Stefanou V, Tsakni A, Timbis D, Vougiouka PA, Doumi I, Maronikolaki I et al. Pomegranate as an Antibacterial Agent against Pathogens and at the same Time Advantageous to Beneficial Bacteria: A Review. Int J Adv Res MicroBiol Immunol 2020; 2(2): 1-13.
Copyright (c) 2021 International Journal of Advanced Research in Microbiology and Immunology
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
We, the undersigned, give an undertaking to the following effect with regard to our article entitled
________________________________________________________________________________” submitted for publication in (Journal title)________________________________________________ _______________________________________________________Vol.________, Year _________:-
1. The article mentioned above has not been published or submitted to or accepted for publication in any form, in any other journal.
2. We also vouchsafe that the authorship of this article will not be contested by anyone whose name(s) is/are not listed by us here.
3. I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.
4. I/We hereby acknowledge ADRs conflict of interest policy requirement to scrupulously avoid direct and indirect conflicts of interest and, accordingly, hereby agree to promptly inform the editor or editor's designee of any business, commercial, or other proprietary support, relationships, or interests that I/We may have which relate directly or indirectly to the subject of the work.
5. I/We also agree to the authorship of the article in the following sequence:-
Authors' Names (in sequence) Signature of Authors
1. _____________________________________ _____________________________________
2. _____________________________________ _____________________________________
3. _____________________________________ _____________________________________
4. _____________________________________ _____________________________________
5. _____________________________________ _____________________________________
6. _____________________________________ _____________________________________
7. _____________________________________ _____________________________________
8. _____________________________________ _____________________________________
(I). All the authors are required to sign independently in this form in the sequence given above. In case an author has left the institution/ country and whose whereabouts are not known, the senior author may sign on his/ her behalf taking the responsibility.
(ii). No addition/ deletion/ or any change in the sequence of the authorship will be permissible at a later stage, without valid reasons and permission of the Editor.
(iii). If the authorship is contested at any stage, the article will be either returned or will not be
processed for publication till the issue is solved.